Quality indicators for the diagnosis and surgical management of breast cancer in South Africa
Open Access
- 1 December 2020
- journal article
- research article
- Published by Elsevier in The Breast
- Vol. 54, 187-196
Abstract
No abstract availableKeywords
Funding Information
- NIH
- National Cancer Institute (R01-CA192627, P30-CA13696)
- South African Medical Research Council
This publication has 48 references indexed in Scilit:
- Multidisciplinary breast centres in Germany: a review and update of quality assurance through benchmarking and certificationArchives of Gynecology and Obstetrics, 2012
- Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trialsThe Lancet, 2011
- Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trialThe Lancet Oncology, 2010
- A systematic review and meta-analysis of the volume-outcome relationship in the surgical treatment of breast cancer. Are breast cancer patients better of with a high volume provider?European Journal of Surgical Oncology, 2010
- Morbidity results from the NSABP B‐32 trial comparing sentinel lymph node dissection versus axillary dissectionJournal of Surgical Oncology, 2010
- International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatmentAnnals of Oncology, 2010
- Analysis of local and regional recurrences in breast cancer after conservative surgeryAnnals of Oncology, 2009
- The health and health system of South Africa: historical roots of current public health challengesThe Lancet, 2009
- Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled studyThe Lancet Oncology, 2006
- Twenty-Year Follow-up of a Randomized Study Comparing Breast-Conserving Surgery with Radical Mastectomy for Early Breast CancerNew England Journal of Medicine, 2002